
Annapoorna Kini
Director, Interventional Cardiology Fellowship · Icahn School of Medicine at Mount Sinai
Credentials: · · · ·
History
- 1997–1998
Interventional Cardiology
- 1994–1997
Cardiovascular Disease
- 1991–1994
Internal Medicine
- 1987–1991
Doctor of Medicine
Research
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease
New England Journal of Medicine · 2015 · 519 citations
The Lancet · 2013 · 494 citations
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS
Journal of the American College of Cardiology · 2016 · 492 citations

428 papers

214 papers · 1 as a fellow

197 papers

145 papers · 10 as a fellow

106 papers

98 papers

94 papers

89 papers
Clinical trials
- 2025–2027
Principal investigator · Recruiting
Annapoorna Kini
- 2022–2025
Principal investigator · Terminated
Icahn School of Medicine at Mount Sinai
- 2021–2023
Effect of Evolocumab on Coronary Plaque Characteristics
Principal investigator · Completed · Phase 4
Annapoorna Kini
- 2020–2022
Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
Principal investigator · Completed
Icahn School of Medicine at Mount Sinai

